IBDEI2LU ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41604,2)
;;=^5007455
;;^UTILITY(U,$J,358.3,41605,0)
;;=I69.293^^155^2061^16
;;^UTILITY(U,$J,358.3,41605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41605,1,3,0)
;;=3^Ataxia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,41605,1,4,0)
;;=4^I69.293
;;^UTILITY(U,$J,358.3,41605,2)
;;=^5007487
;;^UTILITY(U,$J,358.3,41606,0)
;;=I69.093^^155^2061^14
;;^UTILITY(U,$J,358.3,41606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41606,1,3,0)
;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,41606,1,4,0)
;;=4^I69.093
;;^UTILITY(U,$J,358.3,41606,2)
;;=^5007423
;;^UTILITY(U,$J,358.3,41607,0)
;;=I69.893^^155^2061^15
;;^UTILITY(U,$J,358.3,41607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41607,1,3,0)
;;=3^Ataxia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,41607,1,4,0)
;;=4^I69.893
;;^UTILITY(U,$J,358.3,41607,2)
;;=^5007549
;;^UTILITY(U,$J,358.3,41608,0)
;;=I69.391^^155^2061^17
;;^UTILITY(U,$J,358.3,41608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41608,1,3,0)
;;=3^Dysphagia following cerebral infarction
;;^UTILITY(U,$J,358.3,41608,1,4,0)
;;=4^I69.391
;;^UTILITY(U,$J,358.3,41608,2)
;;=^5007516
;;^UTILITY(U,$J,358.3,41609,0)
;;=I69.191^^155^2061^18
;;^UTILITY(U,$J,358.3,41609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41609,1,3,0)
;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,41609,1,4,0)
;;=4^I69.191
;;^UTILITY(U,$J,358.3,41609,2)
;;=^5007453
;;^UTILITY(U,$J,358.3,41610,0)
;;=I69.291^^155^2061^20
;;^UTILITY(U,$J,358.3,41610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41610,1,3,0)
;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,41610,1,4,0)
;;=4^I69.291
;;^UTILITY(U,$J,358.3,41610,2)
;;=^5007485
;;^UTILITY(U,$J,358.3,41611,0)
;;=I69.091^^155^2061^19
;;^UTILITY(U,$J,358.3,41611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41611,1,3,0)
;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,41611,1,4,0)
;;=4^I69.091
;;^UTILITY(U,$J,358.3,41611,2)
;;=^5007421
;;^UTILITY(U,$J,358.3,41612,0)
;;=I69.891^^155^2061^21
;;^UTILITY(U,$J,358.3,41612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41612,1,3,0)
;;=3^Dysphagia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,41612,1,4,0)
;;=4^I69.891
;;^UTILITY(U,$J,358.3,41612,2)
;;=^5007547
;;^UTILITY(U,$J,358.3,41613,0)
;;=I69.321^^155^2061^22
;;^UTILITY(U,$J,358.3,41613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41613,1,3,0)
;;=3^Dysphasia following cerebral infarction
;;^UTILITY(U,$J,358.3,41613,1,4,0)
;;=4^I69.321
;;^UTILITY(U,$J,358.3,41613,2)
;;=^5007492
;;^UTILITY(U,$J,358.3,41614,0)
;;=I69.121^^155^2061^23
;;^UTILITY(U,$J,358.3,41614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41614,1,3,0)
;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,41614,1,4,0)
;;=4^I69.121
;;^UTILITY(U,$J,358.3,41614,2)
;;=^5007428
;;^UTILITY(U,$J,358.3,41615,0)
;;=I69.021^^155^2061^24
;;^UTILITY(U,$J,358.3,41615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41615,1,3,0)
;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,41615,1,4,0)
;;=4^I69.021
;;^UTILITY(U,$J,358.3,41615,2)
;;=^5007396
;;^UTILITY(U,$J,358.3,41616,0)
;;=I69.821^^155^2061^26
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2LU 3760 printed Dec 13, 2024@02:31:15 Page 2
IBDEI2LU ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41604,2)
+2 ;;=^5007455
+3 ;;^UTILITY(U,$J,358.3,41605,0)
+4 ;;=I69.293^^155^2061^16
+5 ;;^UTILITY(U,$J,358.3,41605,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,41605,1,3,0)
+8 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
+9 ;;^UTILITY(U,$J,358.3,41605,1,4,0)
+10 ;;=4^I69.293
+11 ;;^UTILITY(U,$J,358.3,41605,2)
+12 ;;=^5007487
+13 ;;^UTILITY(U,$J,358.3,41606,0)
+14 ;;=I69.093^^155^2061^14
+15 ;;^UTILITY(U,$J,358.3,41606,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,41606,1,3,0)
+18 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
+19 ;;^UTILITY(U,$J,358.3,41606,1,4,0)
+20 ;;=4^I69.093
+21 ;;^UTILITY(U,$J,358.3,41606,2)
+22 ;;=^5007423
+23 ;;^UTILITY(U,$J,358.3,41607,0)
+24 ;;=I69.893^^155^2061^15
+25 ;;^UTILITY(U,$J,358.3,41607,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,41607,1,3,0)
+28 ;;=3^Ataxia following other cerebrovascular disease
+29 ;;^UTILITY(U,$J,358.3,41607,1,4,0)
+30 ;;=4^I69.893
+31 ;;^UTILITY(U,$J,358.3,41607,2)
+32 ;;=^5007549
+33 ;;^UTILITY(U,$J,358.3,41608,0)
+34 ;;=I69.391^^155^2061^17
+35 ;;^UTILITY(U,$J,358.3,41608,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,41608,1,3,0)
+38 ;;=3^Dysphagia following cerebral infarction
+39 ;;^UTILITY(U,$J,358.3,41608,1,4,0)
+40 ;;=4^I69.391
+41 ;;^UTILITY(U,$J,358.3,41608,2)
+42 ;;=^5007516
+43 ;;^UTILITY(U,$J,358.3,41609,0)
+44 ;;=I69.191^^155^2061^18
+45 ;;^UTILITY(U,$J,358.3,41609,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,41609,1,3,0)
+48 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
+49 ;;^UTILITY(U,$J,358.3,41609,1,4,0)
+50 ;;=4^I69.191
+51 ;;^UTILITY(U,$J,358.3,41609,2)
+52 ;;=^5007453
+53 ;;^UTILITY(U,$J,358.3,41610,0)
+54 ;;=I69.291^^155^2061^20
+55 ;;^UTILITY(U,$J,358.3,41610,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,41610,1,3,0)
+58 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
+59 ;;^UTILITY(U,$J,358.3,41610,1,4,0)
+60 ;;=4^I69.291
+61 ;;^UTILITY(U,$J,358.3,41610,2)
+62 ;;=^5007485
+63 ;;^UTILITY(U,$J,358.3,41611,0)
+64 ;;=I69.091^^155^2061^19
+65 ;;^UTILITY(U,$J,358.3,41611,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,41611,1,3,0)
+68 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
+69 ;;^UTILITY(U,$J,358.3,41611,1,4,0)
+70 ;;=4^I69.091
+71 ;;^UTILITY(U,$J,358.3,41611,2)
+72 ;;=^5007421
+73 ;;^UTILITY(U,$J,358.3,41612,0)
+74 ;;=I69.891^^155^2061^21
+75 ;;^UTILITY(U,$J,358.3,41612,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,41612,1,3,0)
+78 ;;=3^Dysphagia following other cerebrovascular disease
+79 ;;^UTILITY(U,$J,358.3,41612,1,4,0)
+80 ;;=4^I69.891
+81 ;;^UTILITY(U,$J,358.3,41612,2)
+82 ;;=^5007547
+83 ;;^UTILITY(U,$J,358.3,41613,0)
+84 ;;=I69.321^^155^2061^22
+85 ;;^UTILITY(U,$J,358.3,41613,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,41613,1,3,0)
+88 ;;=3^Dysphasia following cerebral infarction
+89 ;;^UTILITY(U,$J,358.3,41613,1,4,0)
+90 ;;=4^I69.321
+91 ;;^UTILITY(U,$J,358.3,41613,2)
+92 ;;=^5007492
+93 ;;^UTILITY(U,$J,358.3,41614,0)
+94 ;;=I69.121^^155^2061^23
+95 ;;^UTILITY(U,$J,358.3,41614,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,41614,1,3,0)
+98 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
+99 ;;^UTILITY(U,$J,358.3,41614,1,4,0)
+100 ;;=4^I69.121
+101 ;;^UTILITY(U,$J,358.3,41614,2)
+102 ;;=^5007428
+103 ;;^UTILITY(U,$J,358.3,41615,0)
+104 ;;=I69.021^^155^2061^24
+105 ;;^UTILITY(U,$J,358.3,41615,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,41615,1,3,0)
+108 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
+109 ;;^UTILITY(U,$J,358.3,41615,1,4,0)
+110 ;;=4^I69.021
+111 ;;^UTILITY(U,$J,358.3,41615,2)
+112 ;;=^5007396
+113 ;;^UTILITY(U,$J,358.3,41616,0)
+114 ;;=I69.821^^155^2061^26
